Dear all, Leicester Institute of Structural and Chemical Biology (LISCB) are proud to present six exciting, beautifully-produced short films designed to reach out to industry partners and other stakeholders. We hope you view these as the “front-cover” to a longer story with our academics.
We previously would welcome Industry collaborators, old and new, to our Bench to Business industry open days at the Henry Wellcome Building in Leicester, however, in these challenging times, we found an innovative and entertaining way to bring the scientists to industry. The production of these films was made as part of the University of Leicester’s Industry Academia Exchange (IAX) platform, which is funded by the MRC Proximity to Discovery fund. Five shorts show our scientists outlining their work of either a novel target – including validation, assay development, structural insights and ligand discovery; or development of novel chemical entities with proof of concept against exemplar targets. This information is blended with high quality 3D CGI to make a compelling visual whole. A last film takes the viewer on a virtual tour of our unique structural and chemical biology facilities, and we welcome industrial users to get in touch about what services or research we can provide to aid their drug discovery programmes. LISCB Business Development Manager, Dr Charlotte Walden says “We hope you will spend just a few minutes enjoying our films to learn of our cutting edge technologies and next generation targets. They are designed to be a summary of a translational application, from which we hope to have further discussions with you.” All films can be accessed here: https://www.youtube.com/playlist?list=PLkBZZhQeuA82ygmWIpmOlSBfTDCcxED_F or individually: Facilities Tour introducing our comprehensive and cutting-edge facilities: Cryo EM, X-ray crystallography, NMR, single-molecule techniques, computation and biological chemistry. https://www.youtube.com/watch?v=Ww-pACFWvLE Cyril Dominguez is targeting splicing factors in the discovery of novel therapeutics for complex diseases https://www.youtube.com/watch?v=ruYGmC9jfrs Richard Doveston is developing molecular glue design and discovery strategies and explores stabilisation of 14-3-3 proteins for tumour suppression https://www.youtube.com/watch?v=5nK7hWesUf8 Joanna Fox is potentiating apoptosis through activation of BAK for the treatment of cancer. https://www.youtube.com/watch?v=ytVjPh10hWc Bibek Gooptu has identified the Gal-3 fibrosome as a target in lung fibrosis and inflammation https://www.youtube.com/watch?v=PXfZr1KXjP8 James Hodgkinson and colleagues have developed PROTAC degraders of histone deacetylase enzymes https://www.youtube.com/watch?v=kYi21aFrR2U kind regards, Tennie Dr Tennie Videler LISCB manager Leicester Institute of Structural and Chemical Biology Office 025 Henry Wellcome Building University of Leicester LE1 7HB for now: 07850-996863 LISCB website: https://le.ac.uk/liscb Twitter: @LeicStructBio<https://twitter.com/LeicStructBio> ######################################################################## To unsubscribe from the CCP4BB list, click the following link: https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1 This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list hosted by www.jiscmail.ac.uk, terms & conditions are available at https://www.jiscmail.ac.uk/policyandsecurity/
